Investors will be questioning the chip maker’s strategy for the future more than worrying about its second-quarter earnings ...

My husband recently received a $50,000 inheritance. We have no idea what to do with it. We want to be wise, but everything is ...

Despite expectations for a mixed second quarter, some analysts are staying confident on IBM’s software segment ...

A weaker dollar, the global AI race and plans for ramped-up government spending abroad are all reasons why global equities ...

I have $1.5 million in an IRA and another $1.5 million in a pension from which I can take a lump sum. I also am getting ...

Sarepta Therapeutics said it has paused all shipments of its Elevidys treatment for Duchenne muscular dystrophy in the U.S.

Shares of Verizon VZ are up 4% in premarket trading Monday, after the company said it expects $19.5 billion to $20.5 billion ...

Medicare Advantage could become the default health-insurance program for all older adults. A recent proposal in Congress ...

Figma sets terms in its upcoming initial public offering, and co-founder Dylan Field could net more than $60 million from ...

Stocks hover around record highs. Time for Jim Cramer, CNBC’s hyperbolic stock picker, to freshly embrace the FOMO with ...